"Meaningful use stage 2 e-prescribing threshold and adverse drug events in ..."

Christopher Powers et al. (2015)

> Home

Details and statistics

DOI: 10.1093/JAMIA/OCV036

access: closed

type: Journal Article

metadata version: 2020-05-11

- view
  - electronic edition via DOI
  - unpaywalled version
  authority control:
- export record
  dblp key:
  - journals/jamia/PowersGEMB15
- ask others
- share record
  persistent URL:
  - https://dblp.org/rec/journals/jamia/PowersGEMB15
Christopher Powers, Meghan Hufstader Gabriel, William Encinosa, Farzad Mostashari, Julie Bynum:
Meaningful use stage 2 e-prescribing threshold and adverse drug events in the Medicare Part D population with diabetes. J. Am. Medical Informatics Assoc. 22(5): 1094-1098 (2015)

manage site settings

To protect your privacy, all features that rely on external API calls from your browser are turned off by default. You need to opt-in for them to become active. All settings here will be stored as cookies with your web browser. For more information see our F.A.Q.